| answer text |
<p>Information on spend by the National Health Service in primary and secondary care
is in the table.</p><p> </p><p><strong> </strong></p><p> </p><p>Medicines for the
treatment of hepatitis C have been defined as all medicines contained within British
National Formulary section 5.3.3.4 - chronic hepatitis C. In addition, peginterferon
alfa, ribavirin and interferon alfa have also been included as they have been recommended
in National Institute for Health and Care excellence technology appraisals for use
in treating hepatitis C.</p><p> </p><p> </p><p> </p><p>Since some drugs are prescribed
to treat more than one condition, it may not be possible to separate the different
conditions for which a drug may have been prescribed and therefore figures may include
costs from prescriptions of these drugs other than for hepatitis C.</p><p> </p><p><strong>
</strong></p><p> </p><p>This is the cost of the medicines at NHS list price and not
necessarily the price paid. It does not take account of discounts, dispensing costs,
fees or prescription charges income.</p><p> </p><p> </p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Financial
Year</p></td><td><p>Cost (£000)</p></td></tr><tr><td><p>2011-12</p></td><td><p>34,198.9</p></td></tr><tr><td><p>2012-13</p></td><td><p>52,709.2</p></td></tr><tr><td><p>2013-14</p></td><td><p>72,122.0</p></td></tr></tbody></table><p>
</p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><em>Source:
</em></p><p> </p><p>Prescription Cost Analysis (PCA) provided by the Health and Social
Care Information Centre (primary care)</p><p> </p><p>Hospital Pharmacy Audit Index
(HPAI) provided by IMS Health (secondary care)</p><p> </p><p><strong> </strong></p><p>
</p>
|
|
